Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Cozart RapiScan drug test detects cocaine and opiates in oral fluid
August 15th, 2005
A novel drug test accurately determines cocaine and/or opiate use from saliva samples. Scientists in England conducted a study to "evaluate the efficiency of the Cozart RapiScan (CRS) drug test system for detecting opiates and cocaine in oral fluid." "Oral fluid samples were collected using the Cozart RapiScan collection system from 358 donors who were receiving treatment for their addiction and were monitored for drug misuse," explained G. Cooper and coauthors working at Cozart Bioscience Ltd. in Abingdon. "A further 103 oral fluid samples were collected from volunteer donors who were not drug users." "The samples were analyzed...
Source: Pharma Business Week (2005-08-15)
|
